1203018--10/27/2006--MEDIRECT_LATINO

related topics

{regulation, government, change}

{product, liability, claim}

{product, candidate, development}

{acquisition, growth, future}

{control, financial, internal}

{stock, price, share}

{product, market, service}

{stock, price, operating}

{customer, product, revenue}

We have a history of losses, limited revenues and may not become profitable Limited operating history makes an evaluation of MEDirect s business difficult. We have a limited trading market for our securities and shareholders may not be able to sell at a particular time for a certain price. The application of the penny stock rules could adversely affect the market price of our common shares and increase our transaction costs to sell those shares. We are relying on management to manage our growth strategy otherwise we may not become profitable. Our business is subject to government regulation and our success depends on our ability to maintain full compliance with applicable regulations. We are not profitable and the potential profitability of our business will decrease if recurring orders from our customers are not received. If we cannot obtain our products for the treatment of diabetes at reasonable prices, our profits may decline. We could experience significantly reduced profits if improved technologies that reduce or eliminate the need for consumable testing supplies are developed for glucose monitoring. We could lose customers and revenues to new or existing competitors. Our ability to achieve or maintain profitability will be constrained if we do not effectively manage our anticipated expansion of operations. Currently, the Company does not distribute any products or services which require a pharmacy license, however, if the Company where to distribute pharmaceutical drugs and Pharmacy licensing is delayed , our ability to generate revenues would be diminished. We could be liable for harm caused by products that we sell. If our suppliers or we do not comply with applicable government regulations, we may be prohibited from selling our products. Our quarterly revenues or operating results could vary, which may cause the market price of our common stock to decline. We could experience significantly reduced revenues and profits if Medicare or other government programs change, delay or deny reimbursement. If our suppliers or we do not comply with applicable government regulations, we may be prohibited from selling our products.

Full 10-K form ▸

1203018--10/27/2006--MEDIRECT_LATINO_INC